{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:54Z","timestamp":1792684674773,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.tmaid.2024.102758","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T03:02:14Z","timestamp":1724986934000},"page":"102758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature"],"prefix":"10.1016","volume":"61","author":[{"given":"Aonghus J.","family":"Feeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery A.","family":"Goad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-1658","authenticated-orcid":false,"given":"Gerard T.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2024.102758_bib1","article-title":"Current challenges in the detection and analysis of falsified medicines","volume":"197","author":"Bakker-'t Hart","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.tmaid.2024.102758_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2022.111382","article-title":"Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic","volume":"338","author":"Ziavrou","year":"2022","journal-title":"Forensic Sci Int"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nwh.2018.03.001","article-title":"Public health implications of counterfeit medications","volume":"22","author":"Fantasia","year":"2018","journal-title":"Nurs Womens Health"},{"issue":"20","key":"10.1016\/j.tmaid.2024.102758_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1556\/650.2024.33049","article-title":"Cross-border medicines-database for professionals who provide pre-travel advice","volume":"165","author":"Shmorgun","year":"2024","journal-title":"Orv Hetil"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17157\/mat.10.3.7234","article-title":"The world health organization's engagement with fake drugs, 1948\u20132017","volume":"10","author":"Sirrs","year":"2023","journal-title":"Medicine Anthropology Theory"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib6","first-page":"151","article-title":"Counterfeit drugs and the online pharmaceutical trade, a threat to public safety","volume":"6","author":"O'Hagan","year":"2018","journal-title":"Forensic Research & Criminology International Journal"},{"key":"10.1016\/j.tmaid.2024.102758_bib7","series-title":"Counterfeit drugs: guidelines for the development of measures to combat counterfeit drugs","year":"1999"},{"key":"10.1016\/j.tmaid.2024.102758_bib8","series-title":"Falsified Medicines Directive: are we heading in the right direction?","author":"Frontini","year":"2017"},{"key":"10.1016\/j.tmaid.2024.102758_bib10","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902023e20402","article-title":"Counterfeit medicines: relevance, consequences and strategies to combat the global crisis","volume":"59","author":"Lima","year":"2023","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"36","key":"10.1016\/j.tmaid.2024.102758_bib11","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.5897\/AJPP12.343","article-title":"Counterfeit drugs in Nigeria: a threat to public health","volume":"7","author":"Akinyandenu","year":"2013","journal-title":"African journal of pharmacy and pharmacology"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib12","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/clpt.2009.47","article-title":"Health and economic consequences of counterfeit drugs","volume":"85","author":"Seiter","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib13","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pmed.0020100","article-title":"The global threat of counterfeit drugs: why industry and governments must communicate the dangers","volume":"2","author":"Cockburn","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmaid.2024.102758_bib14","series-title":"Nature, extent, awareness, and attitudes towards counterfeit medicine in Lebanon","author":"Sholy","year":"2015"},{"issue":"12","key":"10.1016\/j.tmaid.2024.102758_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1365-3156.2004.01342.x","article-title":"Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross\u2010sectional survey on the prevalence of fake antimalarials","volume":"9","author":"Dondorp","year":"2004","journal-title":"Trop Med Int Health"},{"issue":"9","key":"10.1016\/j.tmaid.2024.102758_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(06)70581-3","article-title":"Counterfeit anti-infective drugs","volume":"6","author":"Newton","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jphs.12223","article-title":"Public awareness, experiences and views about counterfeit medicines in Lebanon","volume":"9","author":"Sholy","year":"2018","journal-title":"J Pharmaceut Health Serv Res"},{"key":"10.1016\/j.tmaid.2024.102758_bib18","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2024.102758_bib19","author":"Hagmann"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002302","article-title":"Ethical and legal implications of the risks of medical tourism for patients: a qualitative study of Canadian health and safety representatives' perspectives","volume":"3","author":"Crooks","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jlme.12019","article-title":"Medical tourism's impact on health care equity and access in low-and middle-income countries: making the case for regulation","volume":"41","author":"Chen","year":"2013","journal-title":"J Law Med Ethics"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib23","doi-asserted-by":"crossref","first-page":"taz059","DOI":"10.1093\/jtm\/taz059","article-title":"Factors affecting pre-travel health seeking behaviour and adherence to pre-travel health advice: a systematic review","volume":"26","author":"Kain","year":"2019","journal-title":"J Trav Med"},{"issue":"16","key":"10.1016\/j.tmaid.2024.102758_bib24","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.12968\/bjon.2008.17.16.31071","article-title":"Travel health. Part 1: preparing the tropical traveler","volume":"17","author":"Carroll","year":"2008","journal-title":"Br J Nurs"},{"key":"10.1016\/j.tmaid.2024.102758_bib25","series-title":"Principles of pre-travel healthcare","first-page":"1","author":"Torresi","year":"2019"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib26","first-page":"19","article-title":"Fake and counterfeit drugs in the health sector: the role of medical doctors","volume":"2","author":"Akunyili","year":"2004","journal-title":"Ann Ib Postgrad Med"},{"key":"10.1016\/j.tmaid.2024.102758_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2023.102337","article-title":"Scope and predictors of travel medicine practice among primary care physicians in Qatar","volume":"35","author":"Al-Dahshan","year":"2023","journal-title":"Preventive Medicine Reports"},{"key":"10.1016\/j.tmaid.2024.102758_bib28","series-title":"Travel medicine E-book","first-page":"25","article-title":"Pretravel consultation","author":"Hatz","year":"2019"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib29","first-page":"216","article-title":"The health and economic effects of counterfeit drugs","volume":"7","author":"Blackstone","year":"2014","journal-title":"American health & drug benefits"},{"key":"10.1016\/j.tmaid.2024.102758_bib30","author":"Walker"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5958\/2231-5713.2018.00017.X","article-title":"A review on online pharmacy: views and counterviews","volume":"8","author":"Thalkari","year":"2018","journal-title":"Asian Journal of Pharmacy and Technology"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0897190006292949","article-title":"The internet and the globalization of counterfeit drugs","volume":"19","author":"deKieffer","year":"2006","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.tmaid.2024.102758_bib33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.forsciint.2018.08.023","article-title":"Packaging analysis of counterfeit medicines","volume":"291","author":"D\u00e9gardin","year":"2018","journal-title":"Forensic Sci Int"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.medmal.2012.04.007","article-title":"Update on counterfeit antibiotics worldwide; public health risks","volume":"42","author":"Delepierre","year":"2012","journal-title":"Med Maladies Infect"},{"key":"10.1016\/j.tmaid.2024.102758_bib35","series-title":"Trade in counterfeit pharmaceutical products","year":"2020"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/CMR.00072-14","article-title":"Substandard\/counterfeit antimicrobial drugs","volume":"28","author":"Kelesidis","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2024.102758_bib37","series-title":"Counterfeit and substandard drugs in Myanmar and Viet Nam. WHO Report","first-page":"99","author":"Wondemagegnehu","year":"1999"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib38","first-page":"1","article-title":"Surveillance for travel-related disease\u2014GeoSentinel surveillance system, United States, 1997\u20132011","volume":"62","author":"Harvey","year":"2013","journal-title":"Morb Mortal Wkly Rep - Surveillance Summ"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jtm\/tax046","article-title":"What proportion of international travellers acquire a travel-related illness? A review of the literature","volume":"24","author":"Angelo","year":"2017","journal-title":"J Trav Med"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib40","doi-asserted-by":"crossref","first-page":"taw099","DOI":"10.1093\/jtm\/taw099","article-title":"Clostridium difficile infection in returning travellers","volume":"24","author":"Michal Stevens","year":"2017","journal-title":"J Trav Med"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7060.2000.00075","article-title":"Health problems in a large cohort of Americans traveling to developing countries","volume":"7","author":"Hill","year":"2000","journal-title":"J Trav Med"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay053","article-title":"Infectious diseases acquired by international travellers visiting the USA\u2020","volume":"25","author":"Stoney","year":"2018","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102758_bib43","series-title":"Open forum infectious diseases","article-title":"Prescribing patterns of antibiotics for the self-treatment of travelers' diarrhea in Global TravEpiNet, 2009\u20132018","author":"Gandhi","year":"2020"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00052-05","article-title":"Prevention and self-treatment of traveler's diarrhea","volume":"19","author":"Diemert","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2024.102758_bib45","series-title":"The travel and tropical medicine manual E-book","first-page":"112","article-title":"Traveler's diarrhea: prevention and self-treatment","author":"d Ericsson","year":"2016"},{"issue":"9","key":"10.1016\/j.tmaid.2024.102758_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273117","article-title":"Non-prescription acquisition of antibiotics: prevalence, motives, pathways and explanatory factors in the Swedish population","volume":"17","author":"Munthe","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228792","article-title":"Non-prescription purchase of antibiotics during travel abroad among a general adult population in Norway: findings from the seventh Troms\u00f8 Study","volume":"15","author":"Gravningen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.tmaid.2024.102758_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/14787210.2023.2259106","article-title":"Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance","author":"Sono","year":"2023","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib49","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2214-109X(16)00049-8","article-title":"Pharmacopoeial quality of antimicrobial drugs in southern China","volume":"4","author":"Pan","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.tmaid.2024.102758_bib50","doi-asserted-by":"crossref","DOI":"10.1108\/IJPHM-07-2022-0061","article-title":"Quality of medicines and public health in Latin America and the Caribbean (LAC): a review","author":"Husaini","year":"2023","journal-title":"Int J Pharmaceut Healthc Market"},{"issue":"9754","key":"10.1016\/j.tmaid.2024.102758_bib51","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(10)62118-6","article-title":"Tackling the booming trade in counterfeit drugs","volume":"376","author":"Siva","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib52","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/193229680900300634","article-title":"Is the drugstore safe? Counterfeit diabetes products on the shelves","volume":"3","author":"Cheng","year":"2009","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4269\/ajtmh.18-0003","article-title":"Amoxicillin quality and selling practices in urban pharmacies and drug stores of Blantyre, Malawi","volume":"99","author":"Chikowe","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"50 & 51","key":"10.1016\/j.tmaid.2024.102758_bib54","first-page":"1375","article-title":"Fatal bacterial meningitis possibly associated with substandard ceftriaxone\u2014Uganda","volume":"64","author":"Nickerson","year":"2013","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jac\/dkm109","article-title":"Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence","volume":"60","author":"Kelesidis","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"8967","key":"10.1016\/j.tmaid.2024.102758_bib56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(95)92145-1","article-title":"Drug quality, a contributor to drug resistance?","volume":"346","author":"Taylor","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2024.102758_bib57","first-page":"177","article-title":"Challenges associated with addressing counterfeit medicines in Nigeria: an exploration of pharmacists' knowledge, practices, and perceptions","author":"Adigwe","year":"2022","journal-title":"Integrated Pharm Res Pract"},{"issue":"11","key":"10.1016\/j.tmaid.2024.102758_bib58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.trstmh.2006.01.003","article-title":"Counterfeit and substandard antimalarial drugs in Cambodia","volume":"100","author":"Lon","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl 6","key":"10.1016\/j.tmaid.2024.102758_bib59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4269\/ajtmh.14-0574","article-title":"Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia","volume":"92","author":"Yong","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 6","key":"10.1016\/j.tmaid.2024.102758_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4269\/ajtmh.15-0057","article-title":"A repeat random survey of the prevalence of falsified and substandard antimalarials in the Lao PDR: a change for the better","volume":"92","author":"Tabernero","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jssc.201401301","article-title":"Liquid chromatography with tandem mass spectrometry for the simultaneous identification and quantification of cardiovascular drugs applied to the detection of substandard and falsified drugs","volume":"38","author":"Bernard","year":"2015","journal-title":"J Separ Sci"},{"key":"10.1016\/j.tmaid.2024.102758_bib62","series-title":"Tackling counterfeit drugs: the challenges and possibilities","first-page":"1","author":"Pathak","year":"2023"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib63","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.020302","article-title":"Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies","volume":"9","author":"Antignac","year":"2019","journal-title":"Journal of Global Health"},{"issue":"10","key":"10.1016\/j.tmaid.2024.102758_bib64","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.hlpt.2022.100630","article-title":"COVID-19 and counterfeit vaccines: global implications, new challenges and opportunities","volume":"11","author":"Amankwah-Amoah","year":"2022","journal-title":"Health policy and technology"},{"issue":"17","key":"10.1016\/j.tmaid.2024.102758_bib66","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.vaccine.2019.03.037","article-title":"Avoiding preventable deaths: the scourge of counterfeit rabies vaccines","volume":"37","author":"Taylor","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2024.102758_bib67","article-title":"Fake covid vaccines boost the black market for counterfeit medicines","volume":"375","author":"Srivastava","year":"2021","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib68","first-page":"44","article-title":"The real impact of counterfeit medications","volume":"39","author":"Williams","year":"2014","journal-title":"US Pharmacists"},{"key":"10.1016\/j.tmaid.2024.102758_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100343","article-title":"Ensuring vaccine safety: case studies of falsified influenza vaccines detected in Brazil","volume":"14","author":"da Costa","year":"2023","journal-title":"Vaccine X"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib70","doi-asserted-by":"crossref","first-page":"taz034","DOI":"10.1093\/jtm\/taz034","article-title":"Travel vaccination recommendations and infection risk in HIV-positive travellers","volume":"26","author":"Chang","year":"2019","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2024.102758_bib71","series-title":"And Prevention, The pre-travel consultation","first-page":"26","author":"Chen","year":"2014"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib72","first-page":"96","volume":"6","author":"Islam","year":"2018","journal-title":"An investigation into the quality of medicines in Yangon, Myanmar. Pharmacy"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/pharmacy8010045","article-title":"Substandard and falsified medicines in Myanmar","volume":"8","author":"Sakuda","year":"2020","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib74","first-page":"64","article-title":"Problems of fake anti-malarial drugs in Cambodia","volume":"12","author":"Darina","year":"2017","journal-title":"Cambodia\/Asian Journal of Social Pharmac"},{"issue":"11","key":"10.1016\/j.tmaid.2024.102758_bib75","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.trstmh.2006.01.003","article-title":"Counterfeit and substandard antimalarial drugs in Cambodia","volume":"100","author":"Lon","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/pharmacy7030111","article-title":"A cross-sectional investigation for verification of globalization of falsified medicines in Cambodia, indicated by tablets of sildenafil citrate","volume":"7","author":"Yoshida","year":"2019","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/app5.87","article-title":"Tackling substandard and falsified medicines in the Mekong: national responses and regional prospects","volume":"2","author":"Lamy","year":"2015","journal-title":"Asia Pac Policy Stud"},{"key":"10.1016\/j.tmaid.2024.102758_bib78","series-title":"Pharmacy","article-title":"The health and economic impact of substandard and falsified antimalarials in Myanmar","author":"Han","year":"2020"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib79","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","article-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","volume":"12","author":"Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib80","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4269\/ajtmh.2008.79.662","article-title":"Characterization of \u201cYaa Chud\u201d medicine on the Thailand\u2013Myanmar border: selecting for drug-resistant malaria and threatening public health","volume":"79","author":"Newton","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102758_bib81","series-title":"Availability of anti-malaria drugs in markets and selling behaviors of drug vendors","author":"Aung","year":"2017"},{"key":"10.1016\/j.tmaid.2024.102758_bib82","series-title":"Framing the challenge of poor-quality medicines: problem definition and policy making in Cambodia, Laos, and Thailand","author":"Lamy","year":"2017"},{"issue":"Suppl 6","key":"10.1016\/j.tmaid.2024.102758_bib83","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.14-0725","article-title":"Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa","volume":"92","author":"Renschler","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102758_bib84","series-title":"An evaluation of factors affecting drug quality: evidence from the antimalarial market in Uganda","author":"Atukunda","year":"2015"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102758_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217910","article-title":"The economic impact of substandard and falsified antimalarial medications in Nigeria","volume":"14","author":"Beargie","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.tmaid.2024.102758_bib86","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(15)00255-0","article-title":"Counterfeit antiepileptic drugs threaten community services in Guinea-Bissau and Nigeria","volume":"14","author":"Otte","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmaid.2024.102758_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijcard.2017.04.099","article-title":"Fighting fake medicines: first quality evaluation of cardiac drugs in Africa","volume":"243","author":"Antignac","year":"2017","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.tmaid.2024.102758_bib88","doi-asserted-by":"crossref","first-page":"e3403","DOI":"10.1371\/journal.pone.0003403","article-title":"A nationwide survey of the quality of antimalarials in retail outlets in Tanzania","volume":"3","author":"Kaur","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2710.2004.00568.x","article-title":"The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution","volume":"29","author":"Kayumba","year":"2004","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.tmaid.2024.102758_bib90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.trac.2015.11.009","article-title":"Routine quality control of medicines in developing countries: analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania","volume":"76","author":"H\u00f6llein","year":"2016","journal-title":"TrAC, Trends Anal Chem"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102758_bib91","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2471\/BLT.16.186650","article-title":"Threats posed by stockpiles of expired pharmaceuticals in low-and middle-income countries: a Ugandan perspective","volume":"95","author":"Kamba","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2024.102758_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1818-8","article-title":"Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countries","volume":"16","author":"Newton","year":"2017","journal-title":"Malar J"},{"issue":"10060","key":"10.1016\/j.tmaid.2024.102758_bib93","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/S0140-6736(16)32121-3","article-title":"Curbing the circulation of counterfeit medicines in Nigeria","volume":"388","author":"Fatokun","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib94","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12062-022-09363-9","article-title":"Ageing and health in Africa: assessing how low-and middle-class older adults with chronic illnesses navigate the problem of counterfeit drugs in Nigeria","volume":"15","author":"Ekoh","year":"2022","journal-title":"Journal of Population Ageing"},{"key":"10.1016\/j.tmaid.2024.102758_bib95","author":"Cartwright"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4269\/ajtmh.2004.70.245","article-title":"Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication","volume":"70","author":"Basco","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bushor.2010.01.004","article-title":"Country matters: executives weigh in on the causes and counter measures of counterfeit trade","volume":"53","author":"Stumpf","year":"2010","journal-title":"Bus Horiz"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib98","first-page":"141","article-title":"The business of counterfeit drugs in India: a critical evaluation","volume":"4","author":"Verma","year":"2014","journal-title":"Int J Manag Int Bus Stud"},{"key":"10.1016\/j.tmaid.2024.102758_bib99","article-title":"Generic drug industry in India: the counterfeit spin","author":"Shukla","year":"2009","journal-title":"Journal of Intellectual Property Rights"},{"issue":"9714","key":"10.1016\/j.tmaid.2024.102758_bib100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(10)60214-0","article-title":"India combats confusion over counterfeit drugs","volume":"375","author":"Chatterjee","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2024.102758_bib101","series-title":"IPR issues in counterfeiting: a critical evaluation of Indian pharmaceutical sector","author":"Verma","year":"2014"},{"key":"10.1016\/j.tmaid.2024.102758_bib102","doi-asserted-by":"crossref","DOI":"10.18203\/2320-6012.ijrms20150596","article-title":"Counterfeit drugs in India: significance and impact on pharmacovigilance","author":"Shah","year":"2015","journal-title":"Int J Res Med Sci"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib103","doi-asserted-by":"crossref","DOI":"10.5530\/ijpi.2020.3.47","article-title":"A review on regulatory requirements to prevent counterfeit drugs in India","volume":"10","author":"Mamtashanti","year":"2020","journal-title":"International Journal of Pharmaceutical Investigation"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib104","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0250-474X.151550","article-title":"Current scenario of spurious and substandard medicines in India: a systematic review","volume":"77","author":"Khan","year":"2015","journal-title":"Indian J Pharmaceut Sci"},{"key":"10.1016\/j.tmaid.2024.102758_bib105","series-title":"Vaccine scandal and confidence crisis in China","first-page":"360","author":"Lancet","year":"2018"},{"issue":"10145","key":"10.1016\/j.tmaid.2024.102758_bib106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(18)31725-2","article-title":"China's vaccine production scare","volume":"392","author":"Yuan","year":"2018","journal-title":"Lancet"},{"issue":"3\u20134","key":"10.1016\/j.tmaid.2024.102758_bib107","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2702.2012.04166.x","article-title":"Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons","volume":"22","author":"Binkowska\u2010Bury","year":"2013","journal-title":"J Clin Nurs"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib108","first-page":"12","article-title":"The dangers of sexual enhancement supplements and counterfeit drugs to \u201ctreat\u201d erectile dysfunction. Translational","volume":"6","author":"Chiang","year":"2017","journal-title":"andrology and urology"},{"key":"10.1016\/j.tmaid.2024.102758_bib109","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.36740\/WLek202111215","article-title":"Falsification of medicines and distribution of falsified medicines in Ukraine: criminalistic means of detection and counteraction","author":"Shevchuk","year":"2021","journal-title":"Wiad Lek"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3897\/pharmacia.68.e64723","article-title":"The current state of the pharmaceutical market of Ukraine, quality assurance and falfication of medicines","volume":"68","author":"Eiben","year":"2021","journal-title":"Pharmacia"},{"issue":"10001","key":"10.1016\/j.tmaid.2024.102758_bib111","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(15)00394-3","article-title":"Rise in online pharmacies sees counterfeit drugs go global","volume":"386","author":"Clark","year":"2015","journal-title":"Lancet"},{"issue":"s1","key":"10.1016\/j.tmaid.2024.102758_bib112","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3233\/JRS-150681","article-title":"Fighting trafficking of falsified and substandard medicinal products in Russia","volume":"27","author":"Fayzrakhmanov","year":"2015","journal-title":"Int J Risk Saf Med"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib113","doi-asserted-by":"crossref","first-page":"140","DOI":"10.30525\/2256-0742\/2018-4-5-140-144","article-title":"Financial offenses in the circulation of medicines in the context of globalization","volume":"4","author":"Kuzmenko","year":"2018","journal-title":"Baltic Journal of Economic Studies"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib114","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jicj\/mqr005","article-title":"Why and how to make an international crime of medicine counterfeiting","volume":"9","author":"Attaran","year":"2011","journal-title":"J Int Crim Justice"},{"key":"10.1016\/j.tmaid.2024.102758_bib115","volume":"vol. 44","author":"Rojas-Cort\u00e9s","year":"2020"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010387","article-title":"Counterfeit medicines in Peru: a retrospective review (1997\u20132014)","volume":"6","author":"Medina","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib117","article-title":"Corruption and medicine quality in Latin America: a pilot study","volume":"18","author":"Bate","year":"2018","journal-title":"B E J Econ Anal Pol"},{"issue":"9","key":"10.1016\/j.tmaid.2024.102758_bib118","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2606","article-title":"Evaluating aspects of online medication safety in long-term follow-up of 136 Internet pharmacies: illegal rogue online pharmacies flourish and are long-lived","volume":"15","author":"Fittler","year":"2013","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.tmaid.2024.102758_bib119","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11096-014-0056-1","article-title":"A detailed analysis of online pharmacy characteristics to inform safe usage by patients","volume":"37","author":"Alwon","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.tmaid.2024.102758_bib120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00103-017-2629-3","article-title":"Operation Pangea\u2013standing together in combat against international pharmaceutical crime","volume":"60","author":"Smolka","year":"2017","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz"},{"key":"10.1016\/j.tmaid.2024.102758_bib121","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.03018","article-title":"Fighting the global counterfeit medicines challenge: a consumer-facing communication strategy in the US is an imperative","volume":"12","author":"Ofori-Parku","year":"2022","journal-title":"Journal of Global Health"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102758_bib122","doi-asserted-by":"crossref","DOI":"10.2196\/11115","article-title":"Consumers turning to the internet pharmacy market: cross-sectional study on the frequency and attitudes of Hungarian patients purchasing medications online","volume":"20","author":"Fittler","year":"2018","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.tmaid.2024.102758_bib123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fphar.2017.00268","article-title":"Combating sale of counterfeit and falsified medicines online: a losing battle","volume":"8","author":"Lee","year":"2017","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib124","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/pharmacy10020042","article-title":"Online pharmacies selling prescription drugs: systematic review","volume":"10","author":"Long","year":"2022","journal-title":"Pharmacy"},{"issue":"6","key":"10.1016\/j.tmaid.2024.102758_bib125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.2042-7174.2010.00061.x","article-title":"Classification, location and legitimacy of web-based suppliers of Viagra to the UK","volume":"18","author":"Gallagher","year":"2010","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib126","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.japh.2020.04.020","article-title":"Counterfeit drugs: a major issue for vulnerable citizens throughout the world and in the United States","volume":"61","author":"White","year":"2021","journal-title":"J Am Pharmaceut Assoc"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrclinonc.2015.35","article-title":"After counterfeit Avastin\u00ae\u2014what have we learned and what can be done?","volume":"12","author":"Mackey","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.tmaid.2024.102758_bib129","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006657","article-title":"An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain","volume":"4","author":"Cuomo","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.tmaid.2024.102758_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110819","article-title":"Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: an ethnographic and drug checking study","author":"Friedman","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1742-1241.2011.02826.x","article-title":"Assessing the problem of counterfeit medications in the United Kingdom","volume":"66","author":"Jackson","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.tmaid.2024.102758_bib132","series-title":"Criminal justice and security in Central and Eastern Europe: safety, security, and social control in local communities: conference proceedings","article-title":"Online counterfeit medicine trade in Slovenia","author":"Frange\u017e","year":"2016"},{"key":"10.1016\/j.tmaid.2024.102758_bib133","series-title":"Intellectual priperty crime threat assessment 2022","year":"2022"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib134","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0924-8579(02)00367-9","article-title":"Malaria: still a threat to travellers","volume":"21","author":"Loutan","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib135","first-page":"267","article-title":"Malaria in travelers: epidemiology, disease, and prevention","volume":"12","author":"Kain","year":"1998","journal-title":"Infectious Disease Clinics"},{"key":"10.1016\/j.tmaid.2024.102758_bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1936-3","article-title":"Malaria after international travel: a GeoSentinel analysis, 2003\u20132016","volume":"16","author":"Angelo","year":"2017","journal-title":"Malar J"},{"issue":"9","key":"10.1016\/j.tmaid.2024.102758_bib137","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1365-3156.2004.01291.x","article-title":"The difference between effectiveness and efficacy of antimalarial drugs in Kenya","volume":"9","author":"Amin","year":"2004","journal-title":"Trop Med Int Health"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib138","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1371\/journal.pone.0002132","article-title":"Antimalarial drug quality in the most severely malarious parts of Africa\u2013a six country study","volume":"3","author":"Bate","year":"2008","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.tmaid.2024.102758_bib139","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(17)30528-5","article-title":"Falsified and substandard malaria drugs in Africa","volume":"17","author":"Brower","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib140","first-page":"3","article-title":"An overview of malaria transmission mechanisms, control, and modeling","volume":"11","author":"Savi","year":"2022","journal-title":"Med Sci"},{"key":"10.1016\/j.tmaid.2024.102758_bib141","series-title":"Health and AIDS in 2019 and beyond","first-page":"iii","author":"Whiteside","year":"2018"},{"issue":"10219","key":"10.1016\/j.tmaid.2024.102758_bib142","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"10100","key":"10.1016\/j.tmaid.2024.102758_bib143","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"issue":"6 Suppl","key":"10.1016\/j.tmaid.2024.102758_bib144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.77.203","article-title":"Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?","volume":"77","author":"Goodman","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102758_bib145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpba.2013.01.009","article-title":"Understanding and fighting the medicine counterfeit market","volume":"87","author":"D\u00e9gardin","year":"2014","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"11","key":"10.1016\/j.tmaid.2024.102758_bib146","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1002\/jps.22679","article-title":"The global counterfeit drug trade: patient safety and public health risks","volume":"100","author":"Mackey","year":"2011","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.tmaid.2024.102758_bib147","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s10903-020-00979-7","article-title":"Factors associated with buying medications abroad by nativity and race\/ethnicity in the US","volume":"22","author":"Jang","year":"2020","journal-title":"J Immigr Minority Health"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib148","first-page":"251","article-title":"Pharmaceutical GMP: past, present, and future\u2013a review","volume":"63","author":"Patel","year":"2008","journal-title":"Die Pharmazie-An International Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tmaid.2024.102758_bib149","first-page":"101","article-title":"Good manufacturing practices (GMP) for medicinal products","author":"Karmacharya","year":"2014","journal-title":"Promising Pharmaceuticals"},{"key":"10.1016\/j.tmaid.2024.102758_bib150","first-page":"1","article-title":"Good manufacturing practices (GMP) and related FDA guidelines","author":"Harris","year":"2008","journal-title":"Pharmaceutical Manufacturing Handbook: Regulations and Quality"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib151","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1099-1786(199706)2:2<55::AID-QAJ35>3.0.CO;2-X","article-title":"EU and FDA GMP regulations: overview and comparison","volume":"2","author":"Grazal","year":"1997","journal-title":"Qual Assur J: The Quality Assurance Journal for Pharmaceutical, Health and Environmental Professionals"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib152","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1331\/JAPhA.2008.07069","article-title":"Roles for pharmacy in combatting counterfeit drugs","volume":"48","author":"Ziance","year":"2008","journal-title":"J Am Pharmaceut Assoc"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102758_bib153","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1743-6109.2012.02770.x","article-title":"A survey on illegal and counterfeit medicines for the treatment of erectile dysfunctions in Italy","volume":"9","author":"Gaudiano","year":"2012","journal-title":"J Sex Med"},{"issue":"9272","key":"10.1016\/j.tmaid.2024.102758_bib154","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(00)05085-6","article-title":"Fake artesunate in southeast Asia","volume":"357","author":"Newton","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2024.102758_bib155","series-title":"Guidelines for the development of measures to combat counterfeit drugs","first-page":"1","author":"Drugs","year":"1999"},{"key":"10.1016\/j.tmaid.2024.102758_bib156","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11096-004-0558-3","article-title":"The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999","volume":"26","author":"Syhakhang","year":"2004","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.tmaid.2024.102758_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-8-22","article-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","volume":"8","author":"Onwujekwe","year":"2009","journal-title":"Malar J"},{"issue":"9272","key":"10.1016\/j.tmaid.2024.102758_bib158","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(00)05065-0","article-title":"Pharmacopoeial quality of drugs supplied by Nigerian pharmacies","volume":"357","author":"Taylor","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2024.102758_bib159","unstructured":"Green, M.D., Counterfeit drugs - CDC health information for international travel 2012: the Yellow Book, in CDC health information for international travel 2012: the Yellow Book. 2011, centres for disease control. p. 126."},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1179\/204777312X13419245939485","article-title":"Technology for combating counterfeit medicine","volume":"106","author":"Hall","year":"2012","journal-title":"Pathog Glob Health"},{"issue":"11","key":"10.1016\/j.tmaid.2024.102758_bib161","first-page":"4057","article-title":"Counterfeit (fake) drugs & new technologies to identify it in India","volume":"3","author":"Gupta","year":"2012","journal-title":"Int J Pharmaceut Sci Res"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib162","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41120-019-0032-x","article-title":"Drug manufacturing and access to medicines: the West African story. A literature review of challenges and proposed remediation","volume":"5","author":"Ekeigwe","year":"2019","journal-title":"AAPS Open"},{"key":"10.1016\/j.tmaid.2024.102758_bib163","article-title":"The background and history of counterfeit medicines","author":"Obi-Eyisi","year":"2012","journal-title":"Counterfeit Medicines: Policy, Economics and Countermeasure"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib164","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0253-7613.36541","article-title":"Counterfeit and substandard quality of drugs: the need for an effective and stringent regulatory control in India and other developing countries","volume":"39","author":"Khan","year":"2007","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib165","first-page":"132","article-title":"Pharmaceutical serialization, a global effort to combat counterfeit medicines","volume":"66","author":"Pascu","year":"2020","journal-title":"Acta Marisiensis-Seria Medica"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib166","first-page":"639","article-title":"Prevalence of counterfeit anthelminthic medicines: a cross\u2010sectional survey in Cambodia","volume":"15","author":"Khan","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib167","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0738.84191","article-title":"Counterfeit herbal medicine. International journal of nutrition","volume":"1","author":"Mullaicharam","year":"2011","journal-title":"Pharmacology, Neurological Diseases"},{"key":"10.1016\/j.tmaid.2024.102758_bib168","series-title":"The hidden dangers of falsified and substandard medicines: developing countries are most affected by the illegal trade","author":"Vorrath","year":"2019"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90323-2","article-title":"Sounding out falsified medicines from genuine medicines using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS)","volume":"11","author":"Alfarsi","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib170","article-title":"Awareness of the implementation of the falsified medicines directive among pharmaceutical companies' professionals in the European economic area","volume":"15","author":"W\u0142odarczak","year":"2017","journal-title":"Pharm Pract"},{"issue":"10","key":"10.1016\/j.tmaid.2024.102758_bib171","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.optlaseng.2012.05.016","article-title":"Drug packaging security by means of white-light speckle","volume":"50","author":"Cozzella","year":"2012","journal-title":"Opt Laser Eng"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib172","first-page":"1","article-title":"Fake and counterfeit drug: a review","volume":"3","author":"Buowari","year":"2012","journal-title":"Afrimedic Journal"},{"issue":"7","key":"10.1016\/j.tmaid.2024.102758_bib173","first-page":"1645","article-title":"Counterfeit medicines: a real threat to the society","volume":"2","author":"Sekhar","year":"2011","journal-title":"Int J Pharmaceut Sci Res"},{"key":"10.1016\/j.tmaid.2024.102758_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121592","article-title":"The era of fake medicines: investigating counterfeit medicinal products for erectile dysfunction disguised as herbal supplements","volume":"617","author":"Ho","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.tmaid.2024.102758_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40545-016-0078-2","article-title":"Fighting falsified medicines with paperwork\u2013a historic review of Danish legislation governing distribution of medicines","volume":"9","author":"Borup","year":"2016","journal-title":"Journal of Pharmaceutical Policy and Practice"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib176","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.sapharm.2008.05.002","article-title":"Safeguarding against substandard\/counterfeit drugs: mitigating a macroeconomic pandemic","volume":"5","author":"Wertheimer","year":"2009","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.tmaid.2024.102758_bib177","series-title":"Machine learning and information processing: proceedings of ICMLIP 2019","article-title":"A blockchain based model to eliminate drug counterfeiting","author":"Sahoo","year":"2020"},{"key":"10.1016\/j.tmaid.2024.102758_bib178","series-title":"2019 11th international conference on communication systems & networks (COMSNETS)","article-title":"Traceability of counterfeit medicine supply chain through Blockchain","author":"Kumar","year":"2019"},{"key":"10.1016\/j.tmaid.2024.102758_bib179","first-page":"833","article-title":"How reimportation jeopardizes the safety of the US pharmaceutical drug supply under the federal trade commission amendment","author":"Bates","year":"2005","journal-title":"bepress Legal Series"},{"key":"10.1016\/j.tmaid.2024.102758_bib180","article-title":"Counterfeit medicines in less developed countries","author":"Morris","year":"2006","journal-title":"International Policy Network"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib181","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1574886310666151014114633","article-title":"The challenge of counterfeit drugs: a comprehensive review on prevalence, detection and preventive measures","volume":"11","author":"Kumar","year":"2016","journal-title":"Curr Drug Saf"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib182","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1108\/09526860910975643","article-title":"Drug quality in South Africa: perceptions of key players involved in medicines distribution","volume":"22","author":"Patel","year":"2009","journal-title":"Int J Health Care Qual Assur"},{"issue":"8","key":"10.1016\/j.tmaid.2024.102758_bib183","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-3156.2008.02106.x","article-title":"Substandard medicines in resource\u2010poor settings: a problem that can no longer be ignored","volume":"13","author":"Caudron","year":"2008","journal-title":"Trop Med Int Health"},{"issue":"2","key":"10.1016\/j.tmaid.2024.102758_bib184","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1331\/JAPhA.2012.11085","article-title":"Role of the pharmacist in preventing distribution of counterfeit medications","volume":"52","author":"Chambliss","year":"2012","journal-title":"J Am Pharmaceut Assoc"},{"issue":"5","key":"10.1016\/j.tmaid.2024.102758_bib185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.26719\/emhj.19.058","article-title":"Community pharmacists' perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt","volume":"26","author":"Bashir","year":"2020","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.tmaid.2024.102758_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1170929","article-title":"The role of pharmacists in eliminating counterfeit medicines in Nigeria","volume":"11","author":"Adigwe","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.tmaid.2024.102758_bib187","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.sapharm.2012.05.002","article-title":"Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan","volume":"9","author":"Alfadl","year":"2013","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.tmaid.2024.102758_bib188","series-title":"Travel medicine","first-page":"35","article-title":"Chapter 5 - structure and organization of the pre-travel consultation and general advice for travelers","author":"Acosta","year":"2008"},{"key":"10.1016\/j.tmaid.2024.102758_bib189","series-title":"CDC health information for international travel 2010","first-page":"19","article-title":"Chapter 2 - the pre-travel consultation","author":"Acosta","year":"2009"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.pu.07.050186.001245","article-title":"International drug regulation","volume":"7","author":"Lee","year":"1986","journal-title":"Annu Rev Publ Health"},{"key":"10.1016\/j.tmaid.2024.102758_bib191","series-title":"Assessment of medicines regulatory systems in sub-Saharan African countries. An overview of findings from 26 assessment reports","year":"2010"},{"key":"10.1016\/j.tmaid.2024.102758_bib192","first-page":"383","article-title":"Medicines regulation in Africa: current state and opportunities","volume":"31","author":"Ndomondo-Sigonda","year":"2017","journal-title":"Pharmaceut Med"},{"key":"10.1016\/j.tmaid.2024.102758_bib193","series-title":"Promoting quality of medicines program","article-title":"Media reports on medicine quality: focusing on USAID-assisted countries","author":"McGinnis","year":"2013"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib194","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1473-3099(10)70060-8","article-title":"Building medical regulatory authorities in Africa","volume":"10","author":"Burki","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib195","article-title":"Global health diplomacy and the governance of counterfeit medicines: a mapping exercise of institutional approaches","volume":"1","author":"Mackey","year":"2013","journal-title":"J Health Diplomacy"},{"key":"10.1016\/j.tmaid.2024.102758_bib196","unstructured":"WHO. WHO's relationship with the International Medical Products Anti-Counterfeiting Taskforce 2011 Oct 16 2023]; Available from: https:\/\/apps.who.int\/gb\/sf\/pdf_files\/A_SSFFC_WG4-en.pdf."},{"issue":"1","key":"10.1016\/j.tmaid.2024.102758_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-11-233","article-title":"Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism","volume":"11","author":"Mackey","year":"2013","journal-title":"BMC Med"},{"issue":"Suppl 6","key":"10.1016\/j.tmaid.2024.102758_bib198","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4269\/ajtmh.14-0393","article-title":"Responding to the pandemic of falsified medicines","volume":"92","author":"Nayyar","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2024.102758_bib199","year":"2011"},{"key":"10.1016\/j.tmaid.2024.102758_bib200","series-title":"The Falsified Medicines Directive: how to secure your supply chain","first-page":"169","author":"Smith","year":"2014"},{"issue":"4","key":"10.1016\/j.tmaid.2024.102758_bib201","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/09687637.2017.1369936","article-title":"The Internet and lifestyle drugs: an analysis of demographic characteristics, methods, and motives of online purchasers of illicit lifestyle drugs in The Netherlands","volume":"25","author":"Koenraadt","year":"2018","journal-title":"Drugs Educ Prev Pol"},{"key":"10.1016\/j.tmaid.2024.102758_bib204","article-title":"WCO","year":"2022","journal-title":"501.5 million items seized and participation of 160 WCO Members in Operation STOP II"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893924000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:12:26Z","timestamp":1726359146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893924000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":199,"alternative-id":["S1477893924000759"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102758","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2024.102758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102758"}}